Novel agents in the frontline management of multiple myeloma.

@article{Loong2008NovelAI,
  title={Novel agents in the frontline management of multiple myeloma.},
  author={Herbert H F Loong},
  journal={Hematology/oncology and stem cell therapy},
  year={2008},
  volume={1 4},
  pages={201-9}
}
Significant advances in our understanding of the biology of multiple myeloma have led to exciting new opportunities in treatment. The management of this disease is rapidly changing with a plethora of clinical trials initiated with novel agents, namely thalidomide, lenalidomide and bortezomib, either alone or in conjunction with established modalities such… CONTINUE READING